Single-cell RNA sequencing reveals the communications between tumor microenvironment components and tumor metastasis

Jiatong Li1, Yang Bai2, He Zhang1

  • 1Department of Orthopedics, Shengjing Hospital of China Medical University, Shenyang, China.

Frontiers in Immunology
|September 26, 2024
PubMed
Abstract

Insights

This study identified 92 metastasis-related genes in osteosarcoma, revealing key pathways and 15 hub genes. Findings highlight tumor microenvironment interactions critical for osteosarcoma metastasis and potential therapeutic targets.

Area of Science:

  • Oncology
  • Molecular Biology
  • Bioinformatics

Background:

  • Osteosarcoma is a bone cancer with a poor prognosis due to metastasis.
  • The tumor microenvironment (TME) significantly influences osteosarcoma progression and treatment response.

Purpose of the Study:

  • To investigate the metastatic mechanisms of osteosarcoma.
  • To identify potential therapeutic targets by analyzing metastasis-related genes and their interactions within the TME.

Main Methods:

  • Utilized public datasets (GSE152048, GSE14359, GSE49003) to identify differentially expressed genes (DEGs) in metastatic osteosarcoma.
  • Performed Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway, and protein-protein interaction (PPI) network analyses.
  • Employed CIBERSORT and Seurat for cell type abundance estimation and scRNA-seq analysis, and CellChat for intercellular communication.

Main Results:

  • Identified 92 metastasis-related DEGs (41 upregulated, 51 downregulated).
  • Highlighted key pathways including SCF ubiquitin ligase complex and identified 15 hub genes (e.g., Skp2, KIF20A, CCNF, PHB).
  • Observed increased CD8+ T cells in metastatic tissues and identified eight distinct cell types within the TME, with observed interactions.

Conclusions:

  • Uncovered complex intercellular communications within the osteosarcoma TME.
  • The identified hub genes and pathways offer insights into osteosarcoma metastasis.
  • Findings may pave the way for novel therapeutic strategies targeting osteosarcoma metastasis.